Community Academic Profiles–

Christina Clarke

Back to Profile

Publication Details

  • Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: a population-based study.

    Keegan TH, Glaser SL, Clarke CA, Gulley ML, Craig FE, Digiuseppe JA, Dorfman RF, Mann RB, Ambinder RF. J Clin Oncol. 2005; 23 (30): 7604-13

    Epstein-Barr virus (EBV) in Hodgkin's lymphoma (HL) cells has been considered as a prognostic marker for this heterogeneous disease, but studies have yielded mixed findings, likely because of selected patient series and failure to acknowledge an effect of age on outcome. This study assessed survival after HL in a population-based cohort large enough to examine the joint effects of EBV with other factors including age, sex, and histologic subtype.

    PubMedID: 16186595

Stanford Medicine Resources:

Footer Links: